Biologics World South East Asia 2026

 

Biologics World Southeast Asia is a premier regional platform dedicated to advancing the development, manufacturing, and commercialisation of therapeutic biologics across ASEAN.

The conference convenes senior leaders from biopharma, biotech, CDMOs, academia, regulators, investors, and technology providers to address the strategic opportunities shaping Southeast Asia’s biologics landscape.

As demand for monoclonal antibodies, biosimilars, and next-generation biologics continues to rise across the region, Southeast Asia is emerging as a critical hub for clinical development, manufacturing expansion, and healthcare innovation.

Governments across Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the wider ASEAN region are accelerating investments into life sciences infrastructure, regulatory strengthening, and local production capabilities to enhance healthcare resilience and reduce reliance on imports. The conference explores the full therapeutic biologics value chain — from R&D and translational science to bioprocessing, manufacturing scale-up, CDMO partnerships, and market access.

Through strategic discussions and real-world case studies, the programme highlights regional capabilities, investment priorities, and collaboration opportunities driving the growth of biologics adoption in Southeast Asia.

More Info

---

---